The Pro-inflammatory Effects of Glucocorticoids in the Brain

Frontiers in Endocrinology

Volumn 7, Issue , 2016, Pages

  Duque, Erica de Almeida ^a   Munhoz, Carolina Demarchi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

brain; cytokines; glucocorticoids; glucocorticoids receptors; inflammation; pro inflammatory; steroid hormones

Indexed keywords

EID: 85016142880     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2016.00078     Document Type: Review

References (79)

1. Medzhitov R. Origin and physiological roles of inflammation. Nature (2008) 454(7203):428–35.10.1038/nature07201
2. Saijo K Glass CK. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol (2011) 11(11):775–87.10.1038/nri308622025055
3. Palm NW Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev (2009) 227(1):221–33.10.1111/j.1600-065X.2008.00731.x19120487
4. Akira S. Innate immunity and adjuvants. Philos Trans R Soc Lond B Biol Sci (2011) 366(1579):2748–55.10.1098/rstb.2011.010621893536
5. Strowig T Henao-Mejia J Elinav E Flavell R. Inflammasomes in health and disease. Nature (2012) 481(7381):278–86.10.1038/nature1075922258606
6. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell (2010) 140(6):771–6.10.1016/j.cell.2010.03.00620303867
7. Wensveen FM Jelencic V Valentic S Sestan M Wensveen TT Theurich S et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol (2015) 16(4):376–85.10.1038/ni.312025729921
8. Golia E Limongelli G Natale F Fimiani F Maddaloni V Pariggiano I et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep (2014) 16(9):435.10.1007/s11883-014-0435-z25037581
9. Muller-Ladner U Pap T Gay RE Neidhart M Gay S. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol (2005) 1(2):102–10.10.1038/ncprheum004716932639
10. Baumgart DC Sandborn WJ. Crohn’s disease. Lancet (2012) 380(9853):1590–605.10.1016/S0140-6736(12)60026-922914295
11. Pedersen J LaCasse EC Seidelin JB Coskun M Nielsen OH. Inhibitors of apoptosis (IAPs) regulate intestinal immunity and inflammatory bowel disease (IBD) inflammation. Trends Mol Med (2014) 20(11):652–65.10.1016/j.molmed.2014.09.00625282548
12. Sousa AR Lane SJ Cidlowski JA Staynov DZ Lee TH. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J Allergy Clin Immunol (2000) 105(5):943–50.10.1067/mai.2000.10648610808175
13. Wenzel S. Severe asthma: from characteristics to phenotypes to endotypes. Clin Exp Allergy (2012) 42(5):650–8.10.1111/j.1365-2222.2011.03929.x22251060
14. Donath MY Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol (2011) 11(2):98–107.10.1038/nri292521233852
15. Esser N Paquot N Scheen AJ. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease. Expert Opin Investig Drugs (2015) 24(3):283–307.10.1517/13543784.2015.97480425345753
16. Glass CK Saijo K Winner B Marchetto MC Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell (2010) 140(6):918–34.10.1016/j.cell.2010.02.01620303880
17. Colotta F Allavena P Sica A Garlanda C Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis (2009) 30(7):1073–81.10.1093/carcin/bgp12719468060
18. Schweingruber N Reichardt SD Luhder F Reichardt HM. Mechanisms of glucocorticoids in the control of neuroinflammation. J Neuroendocrinol (2012) 24(1):174–82.10.1111/j.1365-2826.2011.02161.x21615563
19. Sorrells SF Caso JR Munhoz CD Sapolsky RM. The stressed CNS: when glucocorticoids aggravate inflammation. Neuron (2009) 64(1):33–9.10.1016/j.neuron.2009.09.03219840546
20. Beato M Klug J. Steroid hormone receptors: an update. Hum Reprod Update (2000) 6(3):225–36.10.1093/humupd/6.3.22510874567
21. Sakamoto H Takahashi H Matsuda K Nishi M Takanami K Ogoshi M et al. Rapid signaling of steroid hormones in the vertebrate nervous system. Front Biosci (Landmark Ed) (2012) 17:996–1019.10.2741/397022201787
22. McEwen BS Biron CA Brunson KW Bulloch K Chambers WH Dhabhar FS et al. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Brain Res Rev (1997) 23(1–2):79–133.10.1016/S0165-0173(96)00012-4
23. Oakley RH Cidlowski JA. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem (2011) 286(5):3177–84.10.1074/jbc.R110.17932521149445
24. Ligr M Li Y Logan SK Taneja S Melamed J Lepor H et al. Mifepristone inhibits GRbeta coupled prostate cancer cell proliferation. J Urol (2012) 188(3):981–8.10.1016/j.juro.2012.04.102
25. Shahidi H Vottero A Stratakis CA Taymans SE Karl M Longui CA et al. Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem Biophys Res Commun (1999) 254(3):559–65.10.1006/bbrc.1998.99809920778
26. Hinds TD Jr Ramakrishnan S Cash HA Stechschulte LA Heinrich G Najjar SM et al. Discovery of glucocorticoid receptor-beta in mice with a role in metabolism. Mol Endocrinol (2010) 24(9):1715–27.10.1210/me.2009-0411me.2009-041120660300
27. DuBois DC Sukumaran S Jusko WJ Almon RR. Evidence for a glucocorticoid receptor beta splice variant in the rat and its physiological regulation in liver. Steroids (2013) 78(2):312–20.10.1016/j.steroids.2012.11.01423257260
28. Meijsing SH Pufall MA So AY Bates DL Chen L Yamamoto KR. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science (2009) 324(5925):407–10.10.1126/science.116426519372434
29. John S Sabo PJ Thurman RE Sung MH Biddie SC Johnson TA et al. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat Genet (2011) 43(3):264–8.10.1038/ng.75921258342
30. Oakley RH Cidlowski JA. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol (2013) 132(5):1033–44.10.1016/j.jaci.2013.09.00724084075
31. Ratman D Vanden Berghe W Dejager L Libert C Tavernier J Beck IM et al. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Mol Cell Endocrinol (2013) 380(1–2):41–54.10.1016/j.mce.2012.12.01423267834
32. Carruthers CW Suh JH Gustafsson JA Webb P. Phosphorylation of glucocorticoid receptor tau1c transactivation domain enhances binding to CREB binding protein (CBP) TAZ2. Biochem Biophys Res Commun (2015) 457(1):119–23.10.1016/j.bbrc.2014.12.02125511704
33. Li MD Yang X. A retrospective on nuclear receptor regulation of inflammation: lessons from GR and PPARs. PPAR Res (2011) 2011:742785.10.1155/2011/74278521941526
34. Falkenstein E Tillmann HC Christ M Feuring M Wehling M. Multiple actions of steroid hormones – a focus on rapid, nongenomic effects. Pharmacol Rev (2000) 52(4):513–56.
35. De Bosscher K Vanden Berghe W Haegeman G. Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene (2006) 25(51):6868–86.10.1038/sj.onc.120993517072333
36. Beck IM Vanden Berghe W Vermeulen L Yamamoto KR Haegeman G De Bosscher K. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev (2009) 30(7):830–82.10.1210/er.2009-001319890091
37. Karin M Chang L. AP-1 – glucocorticoid receptor crosstalk taken to a higher level. J Endocrinol (2001) 169(3):447–51.10.1677/joe.0.1690447
38. Whitehead D Carter DA. cAMP response element-binding protein phosphorylation and DNA binding activity are increased in the anterior pituitary gland following glucocorticoid depletion. J Mol Endocrinol (1997) 19(3):291–7.10.1677/jme.0.01902919460650
39. Bartholome B Spies CM Gaber T Schuchmann S Berki T Kunkel D et al. Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J (2004) 18(1):70–80.10.1096/fj.03-0328com14718388
40. Boncompagni S Arthurton L Akujuru E Pearson T Steverding D Protasi F et al. Membrane glucocorticoid receptors are localised in the extracellular matrix and signal through the MAPK pathway in mammalian skeletal muscle fibres. J Physiol (2015) 593(12):2679–92.10.1113/JP27050225846902
41. Rhen T Cidlowski JA. Antiinflammatory action of glucocorticoids – new mechanisms for old drugs. N Engl J Med (2005) 353(16):1711–23.10.1056/NEJMra050541
42. Sionov RV Cohen O Kfir S Zilberman Y Yefenof E. Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis. J Exp Med (2006) 203(1):189–201.10.1084/jem.2005043316390935
43. Sundahl N Bridelance J Libert C De Bosscher K Beck IM. Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds. Pharmacol Ther (2015) 152:28–41.10.1016/j.pharmthera.2015.05.00125958032
44. Smith LK Cidlowski JA. Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes. Prog Brain Res (2010) 182:1–30.10.1016/S0079-6123(10)82001-120541659
45. Munhoz CD Lepsch LB Kawamoto EM Malta MB Lima Lde S Avellar MC et al. Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion. J Neurosci (2006) 26(14):3813–20.10.1523/JNEUROSCI.4398-05.200616597735
46. Munhoz CD Sorrells SF Caso JR Scavone C Sapolsky RM. Glucocorticoids exacerbate lipopolysaccharide-induced signaling in the frontal cortex and hippocampus in a dose-dependent manner. J Neurosci (2010) 30(41):13690–8.10.1523/JNEUROSCI.0303-09.201020943909
47. Sorrells SF Munhoz CD Manley NC Yen S Sapolsky RM. Glucocorticoids increase excitotoxic injury and inflammation in the hippocampus of adult male rats. Neuroendocrinology (2014) 100(2–3):129–40.10.1159/00036784925228100
48. Sorrells SF Caso JR Munhoz CD Hu CK Tran KV Miguel ZD et al. Glucocorticoid signaling in myeloid cells worsens acute CNS injury and inflammation. J Neurosci (2013) 33(18):7877–89.10.1523/JNEUROSCI.4705-12.201323637179
49. Frank MG Baratta MV Sprunger DB Watkins LR Maier SF. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun (2007) 21(1):47–59.10.1016/j.bbi.2006.03.00516647243
50. Frank MG Miguel ZD Watkins LR Maier SF. Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav Immun (2010) 24(1):19–30.10.1016/j.bbi.2009.07.008
51. Frank MG Thompson BM Watkins LR Maier SF. Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses. Brain Behav Immun (2012) 26(2):337–45.10.1016/j.bbi.2011.10.00522041296
52. Lehnardt S Massillon L Follett P Jensen FE Ratan R Rosenberg PA et al. Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A (2003) 100(14):8514–9.10.1073/pnas.143260910012824464
53. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in toll-like receptor-mediated neuronal injury. Glia (2010) 58(3):253–63.10.1002/glia.2092819705460
54. Juedes AE Ruddle NH. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J Immunol (2001) 166(8):5168–75.10.4049/jimmunol.166.8.516811290800
55. Olson JK Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol (2004) 173(6):3916–24.10.4049/jimmunol.173.6.391615356140
56. Johnson JD O’Connor KA Deak T Stark M Watkins LR Maier SF. Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav Immun (2002) 16(4):461–76.10.1006/brbi.2001.063812096891
57. Frank MG Barrientos RM Watkins LR Maier SF. Aging sensitizes rapidly isolated hippocampal microglia to LPS ex vivo. J Neuroimmunol (2010) 226(1–2):181–4.10.1016/j.jneuroim.2010.05.022
58. Chapman TR Barrientos RM Ahrendsen JT Maier SF Patterson SL. Synaptic correlates of increased cognitive vulnerability with aging: peripheral immune challenge and aging interact to disrupt theta-burst late-phase long-term potentiation in hippocampal area CA1. J Neurosci (2010) 30(22):7598–603.10.1523/JNEUROSCI.5172-09.201020519534
59. Barrientos RM Thompson VM Kitt MM Amat J Hale MW Frank MG et al. Greater glucocorticoid receptor activation in hippocampus of aged rats sensitizes microglia. Neurobiol Aging (2015) 36(3):1483–95.10.1016/j.neurobiolaging.2014.12.00325559333
60. Weber MD Frank MG Sobesky JL Watkins LR Maier SF. Blocking toll-like receptor 2 and 4 signaling during a stressor prevents stress-induced priming of neuroinflammatory responses to a subsequent immune challenge. Brain Behav Immun (2013) 32:112–21.10.1016/j.bbi.2013.03.00423500798
61. Hermoso MA Matsuguchi T Smoak K Cidlowski JA. Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression. Mol Cell Biol (2004) 24(11):4743–56.10.1128/MCB.24.11.4743-4756.200415143169
62. Wohleb ES Hanke ML Corona AW Powell ND Stiner LM Bailey MT et al. beta-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J Neurosci (2011) 31(17):6277–88.10.1523/JNEUROSCI.0450-11.2011
63. Meylan E Tschopp J Karin M. Intracellular pattern recognition receptors in the host response. Nature (2006) 442(7098):39–44.10.1038/nature0494616823444
64. Man SM Kanneganti TD. Regulation of inflammasome activation. Immunol Rev (2015) 265(1):6–21.10.1111/imr.1229625879280
65. Busillo JM Azzam KM Cidlowski JA. Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome. J Biol Chem (2011) 286(44):38703–13.10.1074/jbc.M111.27537021940629
66. Ding Y Gao ZG Jacobson KA Suffredini AF. Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells. J Pharmacol Exp Ther (2010) 335(3):693–702.10.1124/jpet.110.17197520826566
67. Weber MD Frank MG Tracey KJ Watkins LR Maier SF. Stress induces the danger-associated molecular pattern HMGB-1 in the hippocampus of male Sprague Dawley rats: a priming stimulus of microglia and the NLRP3 inflammasome. J Neurosci (2015) 35(1):316–24.10.1523/JNEUROSCI.3561-14.201525568124
68. Kang R Chen R Zhang Q Hou W Wu S Cao L et al. HMGB1 in health and disease. Mol Aspects Med (2014) 40:1–116.10.1016/j.mam.2014.05.00125010388
69. van Zoelen MA Yang H Florquin S Meijers JC Akira S Arnold B et al. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock (2009) 31(3):280–4.10.1097/SHK.0b013e318186262d19218854
70. Briet M Schiffrin EL. Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol (2010) 6(5):261–73.10.1038/nrneph.2010.3020234356
71. Azibani F Fazal L Chatziantoniou C Samuel JL Delcayre C. Aldosterone mediates cardiac fibrosis in the setting of hypertension. Curr Hypertens Rep (2013) 15(4):395–400.10.1007/s11906-013-0354-323686824
72. Rossignol P Menard J Fay R Gustafsson F Pitt B Zannad F. Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (eplerenone post-acute myocardial infarction heart failure efficacy and survival study) substudy. J Am Coll Cardiol (2011) 58(19):1958–66.10.1016/j.jacc.2011.04.04922032706
73. Sica A Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest (2012) 122(3):787–95.10.1172/JCI5964322378047
74. Herrada AA Contreras FJ Marini NP Amador CA Gonzalez PA Cortes CM et al. Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. J Immunol (2010) 184(1):191–202.10.4049/jimmunol.0802886jimmunol.080288619949098
75. Usher MG Duan SZ Ivaschenko CY Frieler RA Berger S Schutz G et al. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest (2010) 120(9):3350–64.10.1172/JCI4108020697155
76. Cruz-Topete D Cidlowski JA. One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids. Neuroimmunomodulation (2015) 22(1–2):20–32.10.1159/00036272425227506
77. Reul JM Gesing A Droste S Stec IS Weber A Bachmann C et al. The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur J Pharmacol (2000) 405(1–3):235–49.10.1016/S0014-2999(00)00677-411033331
78. Frieler RA Meng H Duan SZ Berger S Schutz G He Y et al. Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia. Stroke (2011) 42(1):179–85.10.1161/STROKEAHA.110.59844121106954
79. Chantong B Kratschmar DV Nashev LG Balazs Z Odermatt A. Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells. J Neuroinflammation (2012) 9:260.10.1186/1742-2094-9-26023190711